HeartRhythm

AUGUST 21, 2024

Among pediatric patients undergoing orthotopic heart transplantation (OHT), 1-12% are reported to need a permanent pacemaker (PPM).1 1 There are limited studies on the outcomes of PPM placement, and the role of implantable cardioverter-defibrillator (ICD) in pediatric OHT remains unclear.

Heart Transplant 40

Heart Transplant Pediatrics Transplant Outcomes 40

ECG Cases

NOVEMBER 5, 2019

Sarah Reid on pediatric appendicitis risk calculator, Sheldon Cheskes & Mark Ramzy on double defibrillation for refractory ventricular fibrillation, Hans Rosenberg & Krishan Yadav on cellulitis clinical pearls, Anand Swaminathan on serratus anterior block, Brit Long on recognition of toxic shock syndrome, Justin Morgenstern on tranexamic acid (..)

Defibrillator 52

Defibrillator Pediatrics 52

HeartRhythm

APRIL 30, 2024

The subcutaneous implantable cardioverter-defibrillator (SICD) was developed with an aim to avoid lead-related complications associated with transvenous ICD (TV-ICD) systems. Patient selection and implant techniques have evolved greatly since that time.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Defibrillator Heart Disease 40

Conquering CHD

MARCH 7, 2024

If they have a pacemaker or not, and a wallet card A wallet card identifying the manufacturer of a pacemaker or defibrillator is very important, especially in case of emergency. For the most part, pediatric cardiologists already do an excellent job with this type of counseling.

Congenital Heart Disease 98

Congenital Heart Disease Congenital Pediatrics Heart Disease 98

DAIC

MAY 9, 2024

The guideline, according to a written statement shared here, reiterates the importance of collaborative decision-making with patients who have HCM and provides updated recommendations for the most effective treatment pathways for adult and pediatric patients. Several recommendations in the new guideline extend to pediatric patients.

Cardiomyopathy 52

Cardiomyopathy Pediatrics Quality of Life Sudden Cardiac Death 52

Cardiometabolic Health Congress

JULY 17, 2024

Praluent (alirocumab) (Approved: 03/11/2024) Extended to pediatric patients aged 8+ with heterozygous familial hypercholesterolemia (HeFH). Join us as we examine the landmark approvals that are revolutionizing patient outcomes.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

Circulation

NOVEMBER 9, 2023

Topics addressed by systematic reviews this year include resuscitation of cardiac arrest from drowning, extracorporeal cardiopulmonary resuscitation for adults and children, calcium during cardiac arrest, double sequential defibrillation, neuroprognostication after cardiac arrest for adults and children, maintaining normal temperature after preterm (..)

Cardiac Arrest 40

Cardiac Arrest Education Defibrillator Pediatrics 40